Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Nov 28, 2023. (Total: 223416Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 4 (of 4 Records)

Query Trace: Hyperplasia and PDE11A[original query]
Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population.
Cancer research 2006 Dec 66 (24): 11571-5.
Horvath Anelia, Giatzakis Christoforos, Robinson-White Audrey, Boikos Sosipatros, Levine Elizabeth, Griffin Kurt, Stein Erica, Kamvissi Virginia, Soni Payal, Bossis Ioannis, de Herder Wouter, Carney J Aidan, Bertherat Jérôme, Gregersen Peter K, Remmers Elaine F, Stratakis Constantine
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jun 14 (12): 4016-24.
Libé Rossella, Fratticci Amato, Coste Joel, Tissier Frédérique, Horvath Anelia, Ragazzon Bruno, Rene-Corail Fernande, Groussin Lionel, Bertagna Xavier, Raffin-Sanson Marie Laure, Stratakis Constantine A, Bertherat Jéro
Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.
The Journal of clinical endocrinology and metabolism 2012 Nov 97 (11): E2063-9.
Vezzosi Delphine, Libé Rossella, Baudry Camille, Rizk-Rabin Marthe, Horvath Anelia, Levy Isaac, René-Corail Fernande, Ragazzon Bruno, Stratakis Constantine A, Vandecasteele Grégoire, Bertherat Jérô
Alterations of Phosphodiesterases in Adrenocortical Tumors.
Frontiers in endocrinology 2016 7 111.
Hannah-Shmouni Fady, Faucz Fabio R, Stratakis Constantine
TOP